Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-12-16Clinical Trial Update: Transcranial Direct Current Stimulation (tDCS) as Therapeutical Strategy for Negative Symptoms in Schizophrenia [Phase 2]
Phase 2 trial evaluating transcranial direct current stimulation for negative symptoms in schizophrenia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-11-20Clinical Trial Update: Once Weekly D-cycloserine for Schizophrenia [Phase 4]
A Phase 4 clinical trial evaluating once-weekly D-cycloserine for schizophrenia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-07-24Clinical Trial Update: Clozapine IM and Aggression in Schizophrenic Patients [Phase 3]
A Phase 3 trial evaluating intramuscular clozapine for aggression in schizophrenia was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-07-08Clinical Trial Update: Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital [Phase 4]
Phase 4 study investigating paliperidone palmitate versus selected oral antipsychotics in adults with schizophrenia recently discharged from…
-
EMA withdrawal · 2013-05-17EMA Application withdrawn: Fanaptum (iloperidone) — Vanda Pharmaceuticals Ltd
The EMA withdrew the application for Fanaptum (iloperidone) by Vanda Pharmaceuticals Ltd for schizophrenia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-01-29Clinical Trial Update: Study Evaluating Safety and Tolerability of Vabicaserin in Patients With Sudden Worsening of Schizophrenia [Phase 2]
A Phase 2 clinical trial evaluating the safety and tolerability of vabicaserin in patients with sudden worsening of schizophrenia has been w…
-
CLINICAL_TRIALS withdrawal · 2012-10-24Clinical Trial Update: Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids [Phase 3]
A Phase 3 clinical trial evaluating adjunctive supplementation with vitamins E and C plus omega-3 fatty acids for schizophrenia was terminat…
-
CLINICAL_TRIALS withdrawal · 2012-03-12Clinical Trial Update: Change in Brain Bioenergetics in Bipolar Disorder in Response to Photic Stimulation [NA]
A clinical trial investigating brain bioenergetics in bipolar disorder (and schizophrenia) in response to photic stimulation has been withdr…
-
CLINICAL_TRIALS withdrawal · 2010-06-29Clinical Trial Update: Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients [Phase 3]
Phase 3 trial evaluating bexarotene and fenretinide as add-on therapy to antipsychotics in schizophrenia and schizoaffective disorder has be…
-
CLINICAL_TRIALS withdrawal · 2009-07-28Clinical Trial Update: Lamictal TM, Haloperidol Decanoate in Schizophrenia [Phase 4]
Phase 4 trial of Lamictal and haloperidol decanoate for schizophrenia has been terminated.
-
CLINICAL_TRIALS withdrawal · 2009-02-24Clinical Trial Update: A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With Schizophrenia [Phase 2]
Pfizer's 6-week Phase 2 multicenter trial of varenicline tartrate for cognitive impairment in schizophrenia has been withdrawn.